In symptomatic peripheral artery disease with T2D, semaglutide increased maximum walking distance at 1 y

🄈 Top 2% JournalSep 1, 2025Annals of internal medicine

Semaglutide may increase maximum walking distance after 1 year in people with peripheral artery disease and type 2 diabetes

AI simplified

Abstract

The study observed associations between cardiovascular health and specific endocrine factors.

  • Cardiovascular health may be influenced by various hormonal levels.
  • Endocrine factors could correlate with heart function metrics.
  • Preliminary findings suggest potential links between hormonal imbalances and cardiovascular risk.

AI simplified

Full Text

Full text is available at the source.